rPeptide

rPeptide is a biotechnology startup founded in 1999 that specializes in the development of recombinant peptides, proteins, antibodies, reagents, and custom services for Alzheimer’s, Parkinson’s, and other neurodegenerative research. The company's slogan "R&D starts at rPeptide" reflects its commitment to driving scientific progress and innovation.

rPeptide's dedication to advancing neurodegenerative research is evident in its mission to fill research gaps and facilitate groundbreaking discoveries. The company prides itself on providing high-quality products and exceptional service to scientists and researchers worldwide, aiming to contribute to a better tomorrow through its scientific contributions.

Despite the absence of specific details regarding the headquarter location and recent investments, rPeptide's longstanding presence in the biotechnology industry underscores its resilience and potential for growth. The niche focus on neurodegenerative research positions the company as a valuable player in the biotechnology sector, offering compelling opportunities for future investment and strategic partnerships.